LAURA VANPATTEN: Open Payments
NPI 1073748919 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 77 payments from 22 companies in 2025. Trend: 2023 $953 · 2024 $1,290 · 2025 $1,567
Food & beverage: $1,467Education: $100
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 10 | $217 |
| AstraZeneca Pharmaceuticals LP | 10 | $186 |
| GENZYME CORPORATION | 8 | $160 |
| Grifols USA, LLC | 6 | $142 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Actelion Pharmaceuticals US, Inc. | 6 | $111 |
| Viatris Specialty LLC | 5 | $74 |
| Verona Pharma, Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
Products named: DUPIXENT, Prolastin-C Liquid, WAKIX, WINREVAIR, OPSUMIT, AIRSUPRA, YUPELRI, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
